According to Data Bridge Market Research new Market report “Asia-Pacific Internal Neuromodulation Devices Market, By Product (Spinal Cord Stimulator (By Lead Type (Percutaneous, Paddle Lead)),, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis), By Battery Type (Primary, Rechargeable), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare), By Country (China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Taiwan, Indonesia, Australia, Rest of APAC) - Trends and Forecast to 2022”, has expected to reach USD 1.9 billion by 2022, from 523.7 million in 2015 growing at the CAGR of 20.1% in the forecast period 2016 to 2022.
Browse Full Report : https://www.databridgemarketresearch.com/reports/asia-pacific-internal-neuromodulation-devices-market
Market Segmentation: APAC Internal Neuromodulation Devices Market
- The market is segmented based on product type, battery type, lead type, by indication, by end user and by geography.
- The Asia-Pacific Internal neuromodulation devices market is segmented into 5 product types Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator and Gastric Nerve Stimulator. The Deep Brain Stimulator segment dominates the Asia-Pacific internal neuromodulator devices market with more than 41,3% market share in 2015 and is expected to grow at the highest CAGR in the forecast period 2016 to 2022 followed by spinal cord stimulator and vagus nerve stimulator. The large market share of DBS devices is owing to the large prevalence of Parkinson’s disease in Asian countries such as China, Japan, India and South Korea. The market is further segmented based on indications of usage into failed back surgery syndrome, conditional regional pain syndrome, eschemia, Parkinson’s disease, Alzheimers, urinary incontinence, faecal incontinenece, epilepsy, gastroparesis and others. The product segments are further divided into rechargeable and primary battery types also for spinal cord stimulators the market is divided into 2 lead types percutaneous and paddle lead.
Geographical Segmentation: APAC Internal Neuromodulation Devices Market
Based on geography the Asia-Pacific Internal neuromodulation devices market is segmented into 11 countries , China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Taiwan, Indonesia, Australia and rest of APAC
Competitive Landscape: APAC Internal Neuromodulation Devices Market
The Asia Pacific internal neuromodulation devices market is highly competitive and the major players have used various strategies such as new product launches, expansions, agreemen ts, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of internal neuromodulation devices market for APAC China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Taiwan, Indonesia, Australia .
The Asia Pacific internal neuromodulation devices market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some of the major players operating in this market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Inc., Nevro Corporation, Cyberonics, Inc. among other companies.
Browse Related Reports:
North America Interventional Neurology Devices Market, By Product (Aneurysm Coiling and Embolization Devices (Embolic Coils, Flow Diversion Devices, Liquid Embolic Devices), Angioplasty Devices (Carotid Artery Stents, Embolic Protection Systems), Micro Support Devices (Microguidewires, Microcatheters), Neurothrombectomy Devices (CLOT Retrieval Devices, Suction and Aspiration Devices, Snares)), By Procedure (Embolization, Angioplasty, Neurothrombectomy, Others), By End-User (Hospitals, Neurology Clinics, Ambulatory Care Centers, Others), By Country (U.S., Canada, Mexico) – Trends and Forecast to 2022
North America Nerve Regenaration and Repair Market, By Type (Biomaterials (Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Neurostimalation (Internal (SCS, DBS, VNS, SNS, GES), External (TENS, TMS, RES))), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis, Nerve Repair (Epineural, Perineural, Group Fascicular Repair), Grafting (Autograft, Allograft, Xenograft)), By End-User (Hospitals, Neurology Clinics, Home Healthcare, Community Healthcare), By Country (U.S., Canada, Mexico) – Trends and Forecast to 2022
https://www.databridgemarketresearch.com/reports/north-america-nerve-repair-and-regeneration-market
Contact:
4th Floor, Mega Center,
Magarpatta City, Pune – 411028
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Visit Data Bridge Blog@ https://www.databridgemarketresearch.com/blog/
